Lung Cancer: Targets and Therapy
Lung Cancer: Targets and Therapy is an international, peer-reviewed, open access journal focusing on lung cancer research, identification of therapeutic targets and the best use of preventative and integrated treatment interventions to achieve improved outcomes, enhanced survival and quality of life for the cancer patient.
Specific topics covered in the journal include:
- Epidemiology, detection and screening
- Cellular research and biomarkers
- Identification of biotargets and agents with novel mechanisms of action
- Optimal clinical use of existing anticancer agents, including combination therapies
- The journal welcomes submitted papers covering original research, basic science, clinical and epidemiological studies, reviews and evaluations, guidelines, expert opinion and commentary, case reports and extended reports.
Lung Cancer: Targets and Therapy will no longer consider meta-analyses for publication.
Categories: Advertising, Arts & Entertainment, Books & Literature, Business
Bionic ID: 655083
Advertising Options
Below are Lung Cancer: Targets and Therapy advertising placement options to consider in your media planning and media buying.
-
E-Newsletter Advertising
- E-Newsletter
-
Magazine Advertising
- 1/2 Page
- 1/3 Page
- 1/4 Page
- 1/6 Page
- Full Page
-
Social Advertising
- Facebook Post
- LinkedIn Post
- Twitter Post
-
Video Advertising
- YouTube Post
-
Online Display Advertising
- 160x600 - Wide Skyscraper - $ 80.00 CPM
- 300x250 - Medium Rectangle - $ 80.00 CPM
- 728x90 - Leaderboard - $ 80.00 CPM
Learn More
To learn more about the Lung Cancer: Targets and Therapy program, submit a request for information. Your request will be sent immediately to the Taylor & Francis ad sales team.
Place an Order
To place an order, contact Lung Cancer: Targets and Therapy or order electronically through Bionic Media Buying Software using ID 655083.